DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "2016 Global Survey on Clinical Next-Generation Sequencing" report to their offering.
The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications.
Lab managers of clinical labs were invited to participate in an online survey during August-November 2016. To qualify for survey participation, respondents had to be working in a private or public laboratory, clinical research institution, reference laboratory, academic medical center facility, hospital lab, or diagnostic company that employs NGS for clinical use. Respondents had to be constant users of this technology, belong to the scientific community, and be in a position to authorize purchases.
Over 184 respondents qualified for the survey including C-level officers, lab managers, directors, physicians, post docs, and principal investigators that had a direct interference with the clinical NGS community.
End users were also evaluated for their ability to authorize purchases or make product recommendations. Respondents indicated a wide range of job titles, such as lab directors, scientists, lab managers, clinicians, pathologists, and lab technicians. In total, about 82% of respondents work in the United States. Nevertheless, this study is considered global because the survey was open to respondents from all countries.
Key Topics Covered:
1. Executive Summary
2. Research Background, Objectives, Methodology, and Respondent Demographics
4. Brand Familiarity of Clinical NGS Providers
5. NGS Clinical Applications
6. NGS for Infectious Disease Testing
7. Instrument and Reagent Purchase Patterns
8. Clinical NGS Data Analysis
For more information about this report visit https://www.researchandmarkets.com/research/mssq36/2016_global